2023-03-15
10:16 |
|
2023-03-06
15:00 |
|
3 p, 658.0 KB |
Deteriorament de la qualitat de vida relacionada amb la salut després d'un diagnòstic de síndrome de Cushing
/
Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ;
Valassi, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Investigadores de l'Hospital de Sant Pau i el Germans Trias i Pujol han estudiat com la síndrome de Cushing afecta la qualitat de vida dels pacients. Tot i que el tractament funcioni, l'exposició continuada a quantitats elevades de cortisol suposa un deteriorament de la qualitat de vida que pot millorar-se si s'informa prèviament de les possibles seqüeles de la síndrome.
Investigadoras del Hospital de Sant Pau y el Germans Trias i Pujol han estudiado cómo el síndrome de Cushing afecta a la calidad de vida de los pacientes. Aunque el tratamiento funcione, la exposición continuada a cantidades elevadas de cortisol supone un deterioro de la calidad de vida que puede mejorarse si se informa previamente de las posibles secuelas del síndrome.
Researchers at the Hospitals of Sant Pau and Germans Trias i Pujol have studied how Cushing's syndrome affects patients' quality of life. Even if the treatment works, continued exposure to high amounts of cortisol leads to a deterioration in quality of life that can be improved if the possible sequelae of the syndrome are reported in advance.
2023
UAB divulga, Febrer 2023, p. 1-2
3 documents
|
|
2023-02-17
12:52 |
|
|
A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas : A Spanish group for sarcoma research (GEIS) retrospective study
/
Martínez-Trufero, J. (Javier Martinez-Trufero. Medical Oncology Department. Hospital Universitario Miguel Servet) ;
Sande-González, L.M.D. (Medical Oncology Department. Complejo Asistencial Universitario de Leon) ;
Luna, P. (Medical Oncology Department. Hospital Universitario Son Espases) ;
Martin-Broto, J. (Medical Oncology Department. Hospital Universitario Virgen del Rocio. Instituto de Biomedicina de Sevilla (IBiS; CSIC. US. HUVR)) ;
Álvarez, R. (Medical Oncology Department. Hospital Universitario Gregorio Marañon) ;
Marquina, G. (Medical Oncology Department. Hospital Universitario Clinico San Carlos) ;
Diaz-Beveridge, R. (Medical Oncology Department. Hospital Politécnico La Fe) ;
Poveda, A. (Medical Oncology Department. Instituto Valenciano de Oncologia) ;
Cano, J.M. (Medical Oncology Department. Hospital General de Ciudad Real) ;
Cruz-Jurado, J. (Medical Oncology Department. Hospital Universitario Canarias) ;
López-Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Salgado, M.A.V. (Medical Oncology Department. Hospital Universitario Ramon y Cajal. RYCIS. CIBERONC) ;
Valverde-Morales, C.M. (Hospital Universitari Vall d'Hebron) ;
Sevilla, I. (Investigación Clínica y Traslacional en Cáncer. Instituto de Investigaciones Biomédicas de Málaga (IBIMA). Medical Oncology Department Hospitales. Universitarios Regional y Virgen de la Victoria de Málaga) ;
Martínez-García, J. (Medical Oncology Department. Hospital Virgen de la Arrixaca) ;
Rubio-Casadevall, J. (Medical Oncology Department. Instituto Catalan Oncologia) ;
Juan, A.D. (Medical Oncology Department. Hospital Marqués de Valdecilla) ;
Carrasco, J.A. (Medical Oncology Department. Hospital Alvaro Cunqueiro) ;
Moura, D.S. (Instituto de Biomedicina de Sevilla (IBiS; CSIC. US. HUVR)) ;
Gurruchaga-Sotes, I. (Javier Martinez-Trufero. Medical Oncology Department. Hospital Universitario Miguel Servet) ;
Gutiérrez, A. (Hematology Department. Hospital Universitario Son Espases)
The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. [...]
2021 -  10.3390/cancers13040792
Cancers, Vol. 13 Núm. 4 (february 2021) , p. 1-15
|
|
2023-02-17
12:52 |
|
|
Who smokes in europe? Data from 12 european countries in the tackshs survey (2017-2018)
/
Gallus, Silvano (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ;
Lugo, Alessandra (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ;
Liu, X. (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ;
Behrakis, P. (Institute of Public Health of the American College of Greece) ;
Boffi, R. (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
Bosetti, C. (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ;
Carreras, G. (Istituto per lo Studio. la Prevenzione e la Rete Oncologica) ;
Chatenoud, L. (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ;
Clancy, Luke (TobaccoFree Research Institute Ireland) ;
Continente, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Dobson, R. (University of Stirling) ;
Effertz, T. (University of Hamburg. Hamburg Business School. Institute for Law & Economics) ;
Filippidis, F.T. (Department of Primary Care and Public Health. Imperial College) ;
Fu, M. (Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias. CIBERES)) ;
Geshanova, G. (Smoke Free Life Coalition) ;
Gorini, G. (Istituto per lo Studio. la Prevenzione e la Rete Oncologica) ;
Keogan, S. (TobaccoFree Research Institute Ireland) ;
Ivanov, H. (Smoke Free Life Coalition) ;
Lopez, María José (Institut d'Investigació Biomèdica Sant Pau) ;
Lopez-Nicolas, A. (Universidad Politécnica de Cartagena) ;
Precioso, J. (Instituto de Educação. Universidade do Minho) ;
Przewozniak, K. (Collegium Civitas) ;
Radu-Loghin, C. (European Network for Smoking Prevention) ;
Ruprecht, A. (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
Semple, S. (University of Stirling) ;
Soriano, J.B. (Hospital Universitario de la Princesa (Madrid)) ;
Starchenko, P. (European Network for Smoking Prevention) ;
Trapero-Bertran, M. (Research Institute for Evaluation and Public Policies (IRAPP). Universitat Internacional de Catalunya (UIC)) ;
Tigova, O. (Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias. CIBERES)) ;
Tzortzi, A.S. (Institute of Public Health of the American College of Greece) ;
Vardavas, C. (Institute of Public Health of the American College of Greece) ;
Vyzikidou, V.K. (Institute of Public Health of the American College of Greece) ;
Colombo, P. (DOXA Institute) ;
Fernandez, E. (Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias. CIBERES))
Background: Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking from a large cross-sectional survey, conducted in selected European countries. [...]
2021 - 10.2188/jea.JE20190344
Journal of Epidemiology, Vol. 31 Núm. 2 (2021) , p. 145-151
|
|
2023-02-17
12:52 |
|
|
Smoking and inequalities in mortality in 11 European countries : a birth cohort analysis
/
Long, D. (Department of Public Health. Erasmus MC) ;
Mackenbach, J. (Department of Public Health. Erasmus MC) ;
Martikainen, P. (Population Research Unit. Faculty of Social Sciences. University of Helsinki) ;
Lundberg, O. (Department of Public Health Sciences. Stockholm University) ;
Brønnum-Hansen, H. (Department of Public Health. University of Copenhagen) ;
Bopp, M. (Epidemiology. Biostatistics and Prevention Institute. University of Zurich) ;
Costa, G. (Department of Clinical Medicine and Biology. University of Turin) ;
Kovács, K. (Demographic Research Institute) ;
Leinsalu, M. (Department of Epidemiology and Biostatistics. National Institute for Health Development) ;
Rodríguez-Sanz, Maica (Institut d'Investigació Biomèdica Sant Pau) ;
Menvielle, G. (Sorbonne Université. INSERM. Institut Pierre Louis d'Epidémiologie et de Santé Publique) ;
Nusselder, W. (Department of Public Health. Erasmus MC)
Purpose: To study the trends of smoking-attributable mortality among the low and high educated in consecutive birth cohorts in 11 European countries. Methods: Register-based mortality data were collected among adults aged 30 to 79 years in 11 European countries between 1971 and 2012. [...]
2021 - 10.1186/s12963-021-00247-2
Population Health Metrics, Vol. 19 Núm. 1 (december 2021) , p. 3
|
|
2023-02-17
12:52 |
|
|
Accelerated long-term forgetting over three months in asymptomatic APOE ɛ4 carriers
/
Tort-Merino, A. (Institute of Neurosciences. University of Barcelona) ;
Laine, M. (Department of Psychology. Åbo Akademi University) ;
Valech, N. (Hospital Clínic i Provincial de Barcelona) ;
Olives, J. (Institute of Neurosciences. University of Barcelona) ;
León, M. (Hospital Clínic i Provincial de Barcelona) ;
Ecay-Torres, M. (Centro de Investigación y Terapias Avanzadas. Neurología. CITA-Alzheimer Foundation) ;
Estanga, A. (Centro de Investigación y Terapias Avanzadas. Neurología. CITA-Alzheimer Foundation) ;
Martínez-Lage, P. (Centro de Investigación y Terapias Avanzadas. Neurología. CITA-Alzheimer Foundation) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Sánchez-Valle, R. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rami Gonzalez, Lorena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rodríguez-Fornells, A. (Institució Catalana de Recerca i Estudis Avançats)
Accelerated long-term forgetting (ALF) refers to a rapid loss of information over days or weeks despite normal acquisition/encoding. Notwithstanding its potential relevance as a presymptomatic marker of cognitive dysfunction, no study has addressed the relationship between ALF and Alzheimer's disease (AD) biomarkers. [...]
2021 - 10.1002/acn3.51245
Annals of Clinical and Translational Neurology, Vol. 8 Núm. 2 (february 2021) , p. 477-484
|
|
2023-02-17
11:16 |
|
|
Management of Parkinson's disease and other movement disorders in women of childbearing age : Part 2 Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: parte 2
/
García-Ramos, R. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Santos-García, D. (Complejo Hospitalario Universitario de A Coruña (CHUAC)) ;
Alonso-Cánovas, A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Álvarez-Sauco, M. (Hospital General Universitario de Elche) ;
Ares, B. (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Ávila, A. (Consorci Sanitari Integral. Hospital Sant Joan Despí Moisés Broggi) ;
Caballol, N. (Consorci Sanitari Integral. Hospital Sant Joan Despí Moisés Broggi) ;
Carrillo, F. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Escamilla Sevilla, F. (Instituto de Investigación Biosanitaria (IBS). Hospital Universitario Virgen de las Nieves) ;
Freire, E. (Hospital General Universitario de Elche) ;
Gómez Esteban, J.C. (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Legarda, I. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
López Manzanares, L. (Hospital Universitario de la Princesa (Madrid)) ;
López Valdés, E. (Instituto de Investigación Sanitaria San Carlos (IdISCC). Hospital Clínico San Carlos) ;
Martínez-Torres, I. (Hospital Universitari i Politècnic La Fe (València)) ;
Mata, M. (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Pareés, I. (Hospital Rúber Internacional) ;
Pascual-Sedano, Berta (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez Castrillo, J.C. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Mir, P. (Hospital Rúber Internacional)
Introduction: Many diseases associated with hyperkinetic movement disorders manifest in women of childbearing age. It is important to understand the risks of these diseases during pregnancy, and the potential risks of treatment for the fetus. [...]
2021 - 10.1016/j.nrl.2020.05.012
Neurologia, Vol. 36 Núm. 2 (marzo 2021) , p. 159-168
|
|
2023-02-17
11:16 |
|
|
Management of Parkinson's disease and other movement disorders in woman of childbearing age : Part 1 Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: Parte 1
/
García-Ramos, R. (Hospital Clínico San Carlos (Madrid)) ;
Santos-García, D. (CHUAC (Complejo Hospitalario Universitario de A Coruña)) ;
Alonso-Cánovas, A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Álvarez-Sauco, M. (Hospital General Universitario de Elche) ;
Ares, B. (Hospital Universitario de Santiago de Compostela. Santiago de Compostela) ;
Ávila, A. (Hospital Sant Joan Despí Moisés Broggi. Consorci Sanitari Integral) ;
Caballol, N. (Hospital Sant Joan Despí Moisés Broggi. Consorci Sanitari Integral) ;
Carrillo, F. (Unidad de Trastornos del Movimiento. Servicio de Neurología y Neurofisiología Clínica. Instituto de Biomedicina de Sevilla. Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)) ;
Escamilla Sevilla, F. (Hospital Universitario Virgen de las Nieves. Instituto de Investigación Biosanitaria ibs) ;
Freire, E. (Hospital General Universitario de Elche) ;
Gómez Esteban, J.C. (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Legarda, I. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
López Manzanares, L. (Hospital Universitario de la Princesa (Madrid)) ;
López Valdés, E. (Hospital Clínico San Carlos (Madrid)) ;
Martínez-Torres, I. (Hospital Universitari i Politècnic La Fe (València)) ;
Mata, M. (Hospital Universitario Infanta Sofía. San Sebastián de los Reyes) ;
Pareés, I. (Hospital Ruber Internacional) ;
Pascual-Sedano, Berta (Institut d'Investigació Biomèdica Sant Pau) ;
Mir, P. (Unidad de Trastornos del Movimiento. Servicio de Neurología y Neurofisiología Clínica. Instituto de Biomedicina de Sevilla. Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)) ;
Martínez Castrillo, J.C. (Hospital Universitario Ramón y Cajal (Madrid))
Introduction: The main challenge of Parkinson's disease in women of childbearing age is managing symptoms and drugs during pregnancy and breastfeeding. The increase in the age at which women are having children makes it likely that these pregnancies will become more common in future. [...]
2021 - 10.1016/j.nrl.2020.05.010
Neurologia, Vol. 36 Núm. 2 (marzo 2021) , p. 149-158
|
|
2023-02-17
11:16 |
|
2023-02-17
11:16 |
|
|
Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure
/
Trejo-Velasco, B. (Cardiology Department. University Hospital of Salamanca. Biomedical Research Institute of Salamanca (IBSAL)) ;
Estevez-Loureiro, R. (Cardiology Department. Alvaro Cunqueiro University Hospital) ;
Carrasco-Chinchilla, F. (Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV)) ;
Fernández-Vázquez, F. (Cardiology Department. University Hospital of Leon) ;
Arzamendi, Dabit (Institut d'Investigació Biomèdica Sant Pau) ;
Pan, M. (Cardiology Department. University Hospital Reina Sofia. University of Cordoba and Maimonides Institute for Biomedical Research (IMIBIC)) ;
Pascual, I. (Heart Area. Asturias Central University Hospital. University of Oviedo. Health Research Institute) ;
Nombela-Franco, L. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Amat-Santos, Ignacio J (Cardiology Department. Clinic University Hospital of Valladolid. Heart Sciences Institute) ;
Freixa, X. (Cardiology Department. Clínic University Hospital of Barcelona. University of Barcelona. Biomedical Research Institute August Pi i Sunyer (IDIBAPS)) ;
Hernández-Antolín, R.A. (Cardiology Department. Ramon y Cajal University Hospital) ;
Trillo-Nouche, R. (Cardiology Department. Clinical University Hospital of Santiago) ;
Ikazuriaga, L.A. (Cardiology Department. University Hospital of Basurto) ;
López-Mínguez, J.R. (Cardiology Department. University Hospital of Badajoz) ;
Cervera, D.S. (Cardiology Department. General University Hospital of Valencia) ;
Sanchis, J. (Cardiology Department. University Clinic Hospital of Valencia. University of Valencia) ;
Diez-Gil, J.L. (Cardiology Department. University & Polytechnical Hospital La Fe) ;
Ruiz-Quevedo, V. (Cardiology Department. University Hospital of Navarra) ;
Urbano-Carrillo, C. (Cardiology Department. Regional University Hospital of Málaga) ;
Becerra-Muñoz, V.M. (Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV)) ;
Benito-González, T. (Cardiology Department. University Hospital of Leon) ;
Li, Chi Hion (Institut d'Investigació Biomèdica Sant Pau) ;
Mesa, D. (Cardiology Department. University Hospital Reina Sofia. University of Cordoba and Maimonides Institute for Biomedical Research (IMIBIC)) ;
Avanzas, Pablo (Heart Area. Asturias Central University Hospital. University of Oviedo. Health Research Institute) ;
Armijo, G. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Serrador-Frutos, A.M. (Cardiology Department. Clinic University Hospital of Valladolid. Heart Sciences Institute) ;
Sanchis, L. (Cardiology Department. Clínic University Hospital of Barcelona. University of Barcelona. Biomedical Research Institute August Pi i Sunyer (IDIBAPS)) ;
Lobán, C.F.G. (Cardiology Department. Ramon y Cajal University Hospital) ;
Cid-álvarez, B. (Cardiology Department. Clinical University Hospital of Santiago) ;
Hernández-García, J.M. (Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV)) ;
Garrote-Coloma, C. (Cardiology Department. University Hospital of Leon) ;
Fernández-Peregrina, E. (Cardiology Department. University Hospital Santa Creu i Sant Pau) ;
Romero, M. (Cardiology Department. University Hospital Reina Sofia. University of Cordoba and Maimonides Institute for Biomedical Research (IMIBIC)) ;
Arguero, V.L. (Heart Area. Asturias Central University Hospital. University of Oviedo. Health Research Institute) ;
Cruz-González, I. (Cardiology Department. University of Salamanca)
Background: Transcatheter mitral valve repair (TMVR) is an effective therapy for high-risk patients with severe mitral regurgitation (MR) but heart failure (HF) readmissions and death remain substantial on mid-term follow-up. [...]
2021 - 10.3390/jcm10051006
Journal of clinical medicine, Vol. 10 Núm. 5 (january 2021) , p. 1-13
|
|
|
|
visitante ::
identificación
Estadísticas de uso
Los más consultados
